<DOC>
	<DOCNO>NCT00384904</DOCNO>
	<brief_summary>The purpose clinical research study assess effect Famotidine give twice daily Atazanavir administer Ritonavir HIV-Infected subject .</brief_summary>
	<brief_title>Drug Interaction Study Famotidine Atazanavir With Ritonavir HIV-Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<criteria>HIVinfected male female subject age 18 65 year old BMI 18 35 kg/m² Prior enrollment subject must currently receive Atazanavir/Ritonavir plus least 2 NRTIs , must plasma HIV RNA &lt; 400 copies/mL CD4 count &gt; 200 cells/mm³</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>